PJ
Payal Jaynesh Patel
About Payal Jaynesh Patel
Payal Jaynesh Patel has 15 years in corporate governance. Holds Director and Designated Partner roles. Currently with 4 companies, including Ticos Omega Pharmaceuticals Private Limited and Ticos Lifesciences Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Ticos Omega Pharmaceuticals Private Limited
U24100GJ2020PTC112474
|
Director | 03 Feb 2020 | 2020 | Active |
Ticos Lifesciences Limited
U24239GJ2008PLC053283
|
Director | 22 Jul 2011 | 2008 | Active |
Ticos Laboratories Private Limited
U24239GJ2010PTC060303
|
Director | 16 Mar 2019 | 2010 | Active |
Ticos Holding Llp
AAG-4753
|
Designated Partner | 27 May 2016 | 2016 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Api Webtrade Private Limited
U74120GJ2015PTC083392
|
Director | 16 Mar 2019 | 2015 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Payal Jaynesh Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Payal Jaynesh Patel
Payal Jaynesh Patel has 15 years in corporate governance. Holds Director and Designated Partner roles. Currently with 4 companies, including Ticos Omega Pharmaceuticals Private Limited and Ticos Lifesciences Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.
Payal Jaynesh Patel is associated with 4 companies as Director and Designated Partner.
Payal Jaynesh Patel has expertise in General Business.
Payal Jaynesh Patel has 15 years in corporate governance.